Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Why I’d buy this under-the-radar dividend stock instead of Vodafone Group plc

Should dividend investors buy this small-cap stock over Vodafone Group plc (LON:VOD)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With a dividend yield of 6.2%, shares in Vodafone (LSE: VOD) are understandably tempting for income investors. But there is one major question to consider: does the telecoms giant have what it takes to deliver market-beating returns for investors?

Share price down 6%

The group’s share price is down 6% from a year ago, despite steady organic growth in service revenues and improving free cash flow. Progress has been slow, but Vodafone seems to be getting there. Although overall group revenues in the last financial year dipped by 4.4%, operating profits soared by 182% to €3.7bn as free cash flow more than doubled to €4.1bn.

Continuing with the momentum into 2017, first quarter service revenues grew by 2.2% to €10.8bn, with good growth across Continental Europe — particularly in Italy and Spain, where it had come under intense pressure from price cutting by its rivals. This slow but steady progress, however, does not seem to have been well received by investors.

Cut-throat competition

And it’s probably for good reasons too, given that Vodafone continues to face cut-throat competition from the industry. Its rivals are keeping prices low, while ramping up spending on new, faster networks and multi-play solutions. Vodafone is having a particularly difficult time in the UK, where it lacks its own pay-TV services — with organic service revenues there falling by 3.2%, in contrast to positive growth in its other European markets.

Add to that the big investments planned for the next few years, Vodafone seems set to face a challenging road ahead. To make matters worse, the company’s debt pile is fast rising, with net debt of £31.2bn, just while new mobile spectrum auctions are looming. This means that, looking ahead, future returns could be less than enthusiastic as these pressures crimp future dividend growth and threaten the mobile network operator’s uncertain recovery.

What’s more, valuations aren’t looking too tempting either, with shares trading on a forecast P/E of 28.

Good momentum

Instead Chesnara (LSE: CSN), the life and pensions consolidator, might be a better buy for dividend investors. The Preston-based company is showing good momentum following the completion of its latest acquisition, Legal and General Nederland, which has since been rebranded as Scildon.

Its Economic Value, a key measure of the insurer’s underlying worth, climbed by almost £100m in the first six months of 2017, to £700m, while group cash generation rose from £13.6m last year to £46.2m. The insurer also boasted of strong financial foundations as its solvency ratio remained resilient, at 143%, despite the impact of recent acquisitions.

Looking ahead, City analysts expect Chesnara to pay shareholders a dividend of 20p a share, which gives shareholders an appealing prospective yield of 5%. The company is highly cash generative and easily affords its annual dividends internally, with dividend cover expected to rise to nearly two times this year.

Valuations are also attractive as shares in the company trade at a 15% discount to its Economic Value, with a forward P/E of just 10.3 indicating that it offers substantial upward re-rating potential.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Here’s how much passive income someone could earn maxing out their ISA allowance for 5 years

Christopher Ruane considers how someone might spend a few years building up their Stocks and Shares ISA to try and…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Was I wrong about Barclays shares, up 196%?

Our writer has watched Barclays shares nearly triple in five years, but stayed on the sidelines. Is he now ready…

Read more »

Wall Street sign in New York City
Investing Articles

Up 17% in 2025, can the S&P 500 power on into 2026?

Why has the S&P 500 done so well this year against a backdrop of multiple challenges? Our writer explains --…

Read more »

National Grid engineers at a substation
Investing Articles

National Grid shares are up 19% in 2025. Why?

National Grid shares have risen by almost a fifth this year. So much for it being a sleepy utility! Should…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Here are the potential dividend earnings from buying 1,000 Aviva shares for the next decade

Aviva has a juicy dividend -- but what might come next? Our writer digs into what the coming decade could…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in December [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Is the unloved Aston Martin share price about to do a Rolls-Royce?

The Aston Martin share price has inflicted a world of pain on Harvey Jones, but he isn't giving up hope…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

How much do you need in a Stocks and Shares ISA to raise 1.7 children?

After discovering the cost of raising a child, James Beard explains why he thinks a Stocks and Shares ISA is…

Read more »